• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  03/19/2009
 
Trade Name:  Lexapro
 
Generic or Proper Name (*):  escitalopram oxalate
 
Indications Studied:  Major depressive disorder in adolescents
 
Therapeutic Category:  Antidepressant
 
Ages Studied:  12-17 years
 
Study #:  5
 
Study Type:  Efficacy/Safety
 
Study Design:  Single-Blind/Placebo/Parallel Group
 
No Patients:  233
 
No Centers:  31
 
No Countries:  7
 
BPCA(B), PREA(P):  B
 
Asian:  4
 
-
-